Patent · US Active

Humanized antibodies to interferon alpha receptor-1 (IFNAR-1)

US8758757B2 · kind B2 · utility

1Cited by
6References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 20, 2010
Grant dateJun 24, 2014
Priority date
Expiry dateDec 1, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/94
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Humanized monoclonal antibodies which bind to IFNAR-1, and related antibody-based compositions and molecules, are disclosed. Also disclosed are pharmaceutical compositions comprising the humanized antibodies and therapeutic and diagnostic methods for using the humanized antibodies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.